Jacobson Pharma Corporation Limited (2633.HK)
HKD 1.25
(-1.57%)
HKD 1.25
(-1.57%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.48 Billion HKD | -35.19% |
| 2022 | 5.38 Billion HKD | 13.14% |
| 2021 | 4.75 Billion HKD | -2.29% |
| 2020 | 4.86 Billion HKD | 6.27% |
| 2019 | 4.58 Billion HKD | 7.5% |
| 2018 | 4.26 Billion HKD | 17.98% |
| 2017 | 3.61 Billion HKD | 21.58% |
| 2016 | 2.97 Billion HKD | 63.01% |
| 2015 | 1.82 Billion HKD | 6.85% |
| 2014 | 1.7 Billion HKD | 17.05% |
| 2013 | 1.45 Billion HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 3.98 Billion HKD | 0.0% |
| 2023 FY | 3.48 Billion HKD | -35.19% |
| 2023 Q4 | 3.48 Billion HKD | 0.0% |
| 2022 Q4 | 5.38 Billion HKD | 0.0% |
| 2022 FY | 5.38 Billion HKD | 13.14% |
| 2022 Q2 | 5.05 Billion HKD | 0.0% |
| 2021 FY | 4.75 Billion HKD | -2.29% |
| 2021 Q4 | 4.75 Billion HKD | 0.0% |
| 2021 Q2 | 4.83 Billion HKD | 0.0% |
| 2020 Q4 | 4.86 Billion HKD | 0.0% |
| 2020 FY | 4.86 Billion HKD | 6.27% |
| 2020 Q2 | 4.81 Billion HKD | 0.0% |
| 2019 Q4 | 4.58 Billion HKD | 0.0% |
| 2019 FY | 4.58 Billion HKD | 7.5% |
| 2019 Q2 | 4.65 Billion HKD | 0.0% |
| 2018 Q4 | 4.26 Billion HKD | 0.0% |
| 2018 Q2 | 4.11 Billion HKD | 0.0% |
| 2018 FY | 4.26 Billion HKD | 17.98% |
| 2017 Q2 | 3.06 Billion HKD | 0.0% |
| 2017 FY | 3.61 Billion HKD | 21.58% |
| 2017 Q4 | 3.61 Billion HKD | 0.0% |
| 2016 Q2 | 2.47 Billion HKD | 0.0% |
| 2016 FY | 2.97 Billion HKD | 63.01% |
| 2016 Q4 | 2.97 Billion HKD | 0.0% |
| 2015 FY | 1.82 Billion HKD | 6.85% |
| 2015 Q4 | 1.82 Billion HKD | 0.0% |
| 2014 FY | 1.7 Billion HKD | 17.05% |
| 2014 Q4 | 1.7 Billion HKD | 0.0% |
| 2013 FY | 1.45 Billion HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -284.241% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 84.513% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -170.889% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -66.428% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -629.289% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | -20.625% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | -23.317% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -101.863% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -313.152% |
| SSY Group Limited | 11.96 Billion HKD | 70.861% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -151.088% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 98.717% |